Skip to main content
OpenTrials

Clinical trial condition

Unresectable Lung Non-Squamous Non-Small Cell Carcinoma

Explore clinical trials studying Unresectable Lung Non-Squamous Non-Small Cell Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Unresectable Lung Non-Squamous Non-Small Cell Carcinoma trial results

Active, Not Recruiting

Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy

NCT03965689

Conditions
Lung Diseases, Lung Neoplasms, Metastatic Lung Non-Small Cell Squamous Carcinoma, +12 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
View Trial Details

Related conditions